0001415889-24-004475.txt : 20240220 0001415889-24-004475.hdr.sgml : 20240220 20240220185311 ACCESSION NUMBER: 0001415889-24-004475 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaBrosse Nicole CENTRAL INDEX KEY: 0001910662 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 24655685 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC DATE OF NAME CHANGE: 20040312 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 4 1 form4-02202024_110227.xml X0508 4 2024-02-16 0001159036 HALOZYME THERAPEUTICS, INC. HALO 0001910662 LaBrosse Nicole C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130 false true false false SVP, CHIEF FINANCIAL OFFICER 0 Common Stock 2024-02-16 4 M 0 5093 0 A 15752 D Common Stock 2024-02-16 4 F 0 2737 36.10 D 13015 D Common Stock 2024-02-16 4 M 0 5329 0 A 18344 D Common Stock 2024-02-16 4 F 0 2864 36.10 D 15480 D Restricted Stock Units 0 2024-02-16 4 M 0 5093 0 D Common Stock 5093 10186 D Restricted Stock Units 0 2024-02-16 4 M 0 5329 0 D Common Stock 5329 15987 D The reported disposition of 2,737 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. The reported disposition of 2,864 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. /s/ James R. Oehler, Attorney-in-Fact 2024-02-20